Aspen Aerogels, Inc.
NYSE:ASPNConstruction
+$0.24 today
- Market cap
- $407.33M
- Beta
- 2.99
- P/E (TTM)
- -4.6
- EPS (TTM)
- -$1.35
Volume 1.17M
Average 1.58M
ASPN Revenue
Total income from selling goods and services before any costs are deducted; the top line of the income statement.
Aspen Aerogels, Inc.NYSE: ASPN
Revenue · Q1 FY2026 · quarter ended Mar 2026
Revenue declines year over year
Q1 FY2026 revenue of $37.88M fell 51.9% year over year, behind the -47.3% change in trailing-twelve-month revenue. Sequentially, it fell 8.4% from the prior quarter. Over 3 fiscal years it compounded at +14.5% a year.
Context
- Revenue increased in 2 of the last 3 fiscal years.
What to watch
Whether revenue reaches the consensus estimate from 4 analysts of $239.61M (-11.6%) for the fiscal year ending Dec 2026, a step up from the -40.1% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $37.88M-8.4% QoQ
- Last fiscal yearDec 2025
- $271.1M-40.1% YoY
- LTMMar 2026
- $230.26M-47.3% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -51.9% | -45.6% | +6.2 pp |
| 1 year | -40.1% | -11.6% | +28.5 pp |
| 3-year CAGR | +14.5% | +16.3% | +1.7 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Revenue history
USD · from the income statement
- Latest · FY2025
- 271.1M USD
- Year-over-year change
- -40.1%
- 4-year CAGR
- +22.2%
| Period | Period end | Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 271.1M | -40.1% |
| FY2024 | 2024-12-31 | 452.7M | +89.6% |
| FY2023 | 2023-12-31 | 238.72M | +32.4% |
| FY2022 | 2022-12-31 | 180.36M | +48.3% |
| FY2021 | 2021-12-31 | 121.62M | — |
Revenue vs competitors
How ASPN compares with its peers on the latest reported figures
- Peers report in different currencies, so revenue is compared through growth and rates rather than absolute size.
- Its year-over-year change of -47.3% is the 8th highest of 9, against a peer median of +1.6%.
- Over three fiscal years its annual growth of +14.5% compares with a peer median of +4.1%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | $3.65B USD | -12.2% | +2.0% | |
| LTM Apr 2026 | $2.98B USD | +1.4% | -12.8% | |
| LTM Apr 2026 | $1.86B USD | +14.2% | +14.6% | |
| LTM Feb 2026 | $1.4B USD | +3.2% | -0.8% | |
| LTM Mar 2026 | $594.72M USD | +72.3% | +24.3% | |
| LTM Mar 2026 | CN¥417.55M CNY | -0.7% | +111.3% | |
| LTM Mar 2026 | $230.26M USD | -47.3% | +14.5% | |
| LTM Mar 2026 | $210.28M USD | +1.8% | -8.5% | |
| FY2025 | €31.56M EUR | -71.3% | +6.1% | |
| LTM Mar 2026 | $0 USD | — | — | |
| Peer median (excluding ASPN) | — | +1.6% | +4.1% | |
Competitors are the stored peer set for ASPN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 121.62M | 180.36M | 238.72M | 452.7M | 271.1M |
| Cost of Revenue | 111.69M | 175.39M | 181.8M | 269.8M | 225.11M |
| Gross Profit | 9.94M | 4.98M | 56.92M | 182.9M | 46M |
| Gross Margin | 8.2% | 2.8% | 23.8% | 40.4% | 17.0% |
| Research & Development | 11.44M | 16.93M | 16.36M | 18.05M | 6.3B |
| Selling, General & Admin | 39.1M | 67.29M | 89.77M | 106.8M | 40.91B |
| Operating Expenses | 50.54M | 84.22M | 106.12M | 128.36M | 97.39M |
| Depreciation & Amortization | 9.44M | 9.22M | 18.18M | 24.41M | 45.16M |
| EBITDA | (27.43M) | (68.41M) | (22.31M) | 51.46M | 5.72B |
| EBITDA Margin | -22.5% | -37.9% | -9.3% | 11.4% | 2108.3% |
| Operating Income | (40.6M) | (79.25M) | (49.2M) | 54.54M | (51.39M) |
| Operating Margin | -33.4% | -43.9% | -20.6% | 12.0% | -19.0% |
| Interest Income | 0 | 1.62M | 6.53M | 0 | 0 |
| Interest Expense | 229K | 5.11M | 5.33M | 11.96M | 6.06B |
| Other Income / Expenses | 3.51M | (3.49M) | 3.39M | (39.45M) | (335.77M) |
| Income Before Tax | (37.09M) | (82.74M) | (45.81M) | 15.09M | (387.16M) |
| Pre-Tax Margin | -30.5% | -45.9% | -19.2% | 3.3% | -142.8% |
| Income Tax Expense | 0 | 0 | 0 | 1.71M | 2.39M |
| Net Income | (37.09M) | (82.74M) | (45.81M) | 13.38M | (389.55M) |
| Net Margin | -30.5% | -45.9% | -19.2% | 3.0% | -143.7% |
| EPS (Basic) | (0.92) | (2.19) | (0.66) | 0.17 | (4.74) |
| EPS (Diluted) | (0.92) | (2.19) | (0.66) | 0.17 | (4.74) |
| Weighted Avg Shares | 30.43M | 39.36M | 69.44M | 77.54M | 82.66M |
| Weighted Avg Shares (Diluted) | 30.43M | 39.36M | 69.44M | 80.31M | 82.66M |
Aspen Aerogels, Inc.
NYSE:ASPN
Intrinsic Alpha fair value
Locked
Current Price
$4.90
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.